Anoscopy

PROCEDURE3 trials

Sponsors

University of Washington, National Cancer Institute (NCI)

Conditions

AIDS-Related Anal CarcinomaAnal Margin Squamous Cell CarcinomaAnal Non-Keratinizing Squamous Cell CarcinomaAnal Squamous Cell CarcinomaHIVHIV Disease ProgressionHIV InfectionHIV-1-infection

Phase 2

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

Active, not recruitingNCT04929028

National Cancer Institute (NCI)AIDS-Related Anal Carcinoma, Anal Margin Squamous Cell Carcinoma, Anal Non-Keratinizing Squamous Cell Carcinoma +7

Start: 2022-08-09End: 2031-09-15Target: 40Updated: 2026-04-03

Unknown Phase

Effects of the Anti-HIV Pill Truvada on Gene Transcription in the Gastrointestinal Tract of HIV-uninfected Individuals

CompletedNCT02621242

University of WashingtonHIV

Start: 2015-12-31End: 2017-12-31Updated: 2024-07-12

Comparing Immune Activation and Latent HIV Reservoir Size Between People Living With HIV on Tenofovir-containing Versus NRTI-free ART

Enrolling by invitationNCT05584397

University of WashingtonHIV, HIV-1-infection, HIV Disease Progression +1

Start: 2022-09-01End: 2025-12-28Target: 40Updated: 2024-12-05